UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000034183
Receipt No. R000038970
Official scientific title of the study Measurement of functional residual capacity by volumetric capnography
Date of disclosure of the study information 2018/09/18
Last modified on 2019/03/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Measurement of functional residual capacity by volumetric capnography
Title of the study (Brief title) Measurement of functional residual capacity by volumetric capnography
Region
Japan

Condition
Condition healthy volunteer
Classification by specialty
Pneumology Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to assess the reliabity of the functional residual capacity(FRC) mesurement using novel volumetric capnography comparied with the helium gas dilution method.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes FRC by using novel volumetric capnography
FRC by the helium gas dilution method
Key secondary outcomes airway dead space
alveolar dead space

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria healty volunteer
Key exclusion criteria 1.current smoker
2.upper respiratory tract infection within 2week
3.history of lung surgery
4.pregnat woman
5.obesity (BMI is over 30kg/m2)
6.those who can not obtain consent
Target sample size 60

Research contact person
Name of lead principal investigator Hiroshi Araki
Organization National Hospital Organization Nagasaki Medical Hospital
Division name Department of Anesthesiology
Address 2-1001-1 Kubara,Oomura-shi,Nagasaki
TEL 0957523121
Email haraki@nagasaki-mc.com

Public contact
Name of contact person Hiroshi Araki
Organization National Hospital Organization Nagasaki Medical Hospital
Division name Department of Anesthesiology
Address 2-1001-1 Kubara,Oomura-shi,Nagasaki
TEL 0957523121
Homepage URL
Email haraki@nagasaki-mc.com

Sponsor
Institute National Hospital Organization Nagasaki Medical Hospital
Institute
Department

Funding Source
Organization No reserch fund
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立病院機構 長崎医療センター(長崎県)

Other administrative information
Date of disclosure of the study information
2018 Year 09 Month 18 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2018 Year 09 Month 01 Day
Anticipated trial start date
2018 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Nothing

Management information
Registered date
2018 Year 09 Month 18 Day
Last modified on
2019 Year 03 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038970